Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage

By Macdonald R Loch  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1761-1767

Informa Healthcare

Access to resources Recommend Favorite

Effect of the putative novel selective ET_A-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery

By Olgun Nicole   Patel Hardik J.   Stephani Ralph   Wang Wei   Yen Haoting   Reznik Sandra E.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 8, 2008-08 ,pp. : 571-575

NRC Research Press

Access to resources Recommend Favorite

The 5-HT 2 receptor antagonist, pelanserin, inhibits 1 -adrenoceptor-mediated vasoconstriction in vitro

By Villalobos-Molina R.   Ibarra M.   Hong E.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 181-185

Elsevier

Access to resources Recommend Favorite

The CRF 1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats

By Lejeune F.   Millan M.J.  

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 127-133

Elsevier

Access to resources Recommend Favorite

Renal effect of YM435, a new dopamine D 1 receptor agonist, in anesthetized dogs

By Yatsu T.   Arai Y.   Takizawa K.   Kasai-Nakagawa C.   Takanashi M.   Uchida W.   Inagaki O.   Tanaka A.   Asano M.   Honda K.   Takenaka T.  

European Journal of Pharmacology, Vol. 322, Iss. 1, 1997-03 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite